Seroprevalence and Manifestations of Ocular Toxoplasmosis in Patients with Schizophrenia

References

• Torrey EF, Yolken RH. Familial and genetic mechanisms in schizophrenia. Brain Res Rev. 2000; 31: 113–117.
   PubMedGoogle Scholar
• Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 2006; 33(3): 729–736.
   PubMed Web of Science ®Google Scholar
• Boothroyd JC, Grigg ME. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Microbiol. 2002; 5: 438–442.
   PubMed Web of Science ®Google Scholar
• Dubey JP. Toxoplasmosis-a waterborne zoonosis. Vet Parasitol. 2004; 126: 57–72.
   PubMed Web of Science ®Google Scholar
• Bahia-Oliveira L, Jones JL, Azevedo-Silva J, Alves CC, Oréfice F, Addiss DG. High endemic waterborne toxoplasmosis in North Rio de Janeiro State, Brazil. Emerg Infect Dis. 2003; 9: 55–62.
   PubMed Web of Science ®Google Scholar
• Ingram WM, Goodrich LM, Robey EA, Eisen MB. PLoS One. 2013; 8: e75246.
   PubMed Web of Science ®Google Scholar
• Yolken RH, Torrey EF. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry. 2008; 13: 470–479.
   PubMed Web of Science ®Google Scholar
• Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 2007; 33: 729–736.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th. text rev Washington, DC: Author; 2000.
   Google Scholar
• Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull. 2006; 32: 200–202.
   PubMed Web of Science ®Google Scholar
• Wang HL, Wang GH, Li QY, Shu C, Jiang MS. Guo Y Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma -seropositive and Toxoplasma -seronegative schizophrenia. Acta Psychiatr Scand. 2006; 114: 40–48.
   PubMed Web of Science ®Google Scholar
• Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Yolken RH. Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull. 2007; 33: 741–744.
   PubMed Web of Science ®Google Scholar
• Leweke FM, Gerth CW, Koethe D, et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004; 254: 4–8.
   PubMed Web of Science ®Google Scholar
• Havlicek J, Gašová Z, Smith AP, Zvára K, Flegr J. Decrease of psychomotor performance in subjects with latent ‘asymptomatic’ toxoplasmosis. Parasitol. 2001; 122: 515–520.
   PubMed Web of Science ®Google Scholar
• Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitol. 2012; 10: 1–50.
   Web of Science ®Google Scholar
• Subauste CS, Ajzenberg D, Kijlstra A. Review of the series ‘Disease of the year 2011: toxoplasmosis’ pathophysiology of toxoplasmosis. Ocul Immunol Inflamm. 2011; 19: 297–306.
   PubMed Web of Science ®Google Scholar
• Shin DW, Cha DY, Hua QJ, Cha GH, Lee YH. Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J Parasitol. 2009; 47: 125–130.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Yin J, Jiang N, et al. Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis. 2010; 10: 4.
   PubMed Web of Science ®Google Scholar
• Kamani J, Mani AU, Egwu GO, Kumshe HA. Seroprevalence of human infection with Toxoplasma gondii and the associated risk factors, in Maiduguri, Borno state, Nigeria. Ann Trop Med Parasitol. 2009; 103: 317–321.
   PubMedGoogle Scholar
• Swai ES, Schoonman L. Seroprevalence of Toxoplasma gondii infection amongst residents of Tanga district in north-east Tanzania. Tanzan J Health Res. 2009; 11: 205–209.
   PubMedGoogle Scholar
• Fromont EG, Riche B, Rabilloud M. Toxoplasma seroprevalence in a rural population in France: detection of a household effect. BMC Infect Dis. 2009; 9: 76.
   PubMed Web of Science ®Google Scholar
• Silveira C, Belfort R Jr, Burnier M Jr, Nussenblatt R. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol. 1988; 106: 362–364.
   PubMed Web of Science ®Google Scholar
• Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am J Trop Med Hyg. 2007; 77: 405–410.
   PubMed Web of Science ®Google Scholar
• Matos G, Guarniero FB, Hallak JE, Bressan RA. Schizophrenia, the forgotten disorder: the scenario in Brazil. Rev Bras Psiquiatr. 2015; 37: 4.
   Web of Science ®Google Scholar
• Almeida-Filho N, Mari Jde J, Coutinho E, et al. Brazilian multicentric study of psychiatric morbidity. Methodological features and prevalence estimates. Br J Psychiatry. 1997; 171: 524–529.
   PubMed Web of Science ®Google Scholar
• Andrade LHSG, Lólio CA, Gentil Filho V, Laurenti R. Epidemiologia dos transtornos mentais em uma area definida de captação da cidade de São Paulo, Brasil. Rev Psiquiatr Clin (São Paulo). 1999; 26: 257–261.
   Google Scholar
• Theme-Filha MM, Szwarcwald CL, Souza-Junior PR. Socio-demographic characteristics, treatment coverage, and self-rated health of individuals who reported six chronic diseases in Brazil, 2003. Cad Saude Publica. 2005; 21: S43–S53.
   PubMedGoogle Scholar
• Holland GN. Ocular toxoplasmosis: the influence of patient age. Mem Inst Oswaldo Cruz. 2009; 104: 2.
   Web of Science ®Google Scholar
• Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol. 2003; 136: 973–988.
   PubMed Web of Science ®Google Scholar
• Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol. 1992; 114: 136–144.
   PubMed Web of Science ®Google Scholar